Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Pittsburgh
With
Pfizer
Women are followed prospectively for 3 months, recording headaches, other symptoms, and menstrual periods. Those with menstrual migraine are treated perimenstrually with eletriptan for 3 months.
Age
18–45
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
age 18-45 healthy menstruating female
You may not be if
cardiac or other conditions precluding use of eletriptan
